This paper is in the following e-collection/theme issue:

Participatory Research Protocols and Proposals (140)

Published on in Vol 5, No 3 (2016): Jul-Sept

Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design

Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design

Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design

Authors of this article:

David Peddie1, 2 Author Orcid Image ;   Serena S Small1, 2 Author Orcid Image ;   Katherin Badke3, 4 Author Orcid Image ;   Maeve E Wickham1, 3 Author Orcid Image ;   Chantelle Bailey1, 3 Author Orcid Image ;   Adam Chruscicki5 Author Orcid Image ;   Christine Ackerley1, 2 Author Orcid Image ;   Ellen Balka1, 2 Author Orcid Image ;   Corinne M Hohl1, 3 Author Orcid Image
Article Authors Cited by (21) Tweetations (6) Metrics

Journals

  1. Chruscicki A, Badke K, Peddie D, Small S, Balka E, Hohl C. Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record. SpringerPlus 2016;5(1) View
  2. Peddie D, Small S, Badke K, Bailey C, Balka E, Hohl C. Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset. JMIR Medical Informatics 2018;6(2):e10248 View
  3. Small S, Peddie D, Ackerley C, Hohl C, Balka E. Patient experiences with informational discontinuity of care: Bridging the gaps. Procedia Computer Science 2017;113:295 View
  4. Hohl C, Small S, Peddie D, Badke K, Bailey C, Balka E. Why Clinicians Don’t Report Adverse Drug Events: Qualitative Study. JMIR Public Health and Surveillance 2018;4(1):e21 View
  5. Lee C, Chen Y. Machine learning on adverse drug reactions for pharmacovigilance. Drug Discovery Today 2019;24(7):1332 View
  6. Small S, Hohl C, Balka E. Organizational implications of implementing a new adverse drug event reporting system for care providers and integrating it with provincial health information systems. Healthcare Management Forum 2019;32(4):208 View
  7. Tillman E, Suppes S, Feldman K, Goldman J. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record. The Journal of Clinical Pharmacology 2021;61(2):181 View
  8. Hau J, Brasher P, Cragg A, Small S, Wickham M, Hohl C. Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial. Trials 2021;22(1) View
  9. Small S, Hohl C, Balka E. Patient Perspectives on Health Data Privacy and Implications for Adverse Drug Event Documentation and Communication: Qualitative Study. Journal of Medical Internet Research 2021;23(1):e21452 View
  10. Fossouo Tagne J, Yakob R, Dang T, Mcdonald R, Wickramasinghe N. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review. JMIR Public Health and Surveillance 2023;9:e40080 View
  11. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy. JMIR Human Factors 2023;10:e43529 View
  12. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework. Interactive Journal of Medical Research 2022;11(2):e40597 View
  13. Li R, Curtis K, Van C, Tabish Razi Zaidi S, Yeo C, Arun Kali C, Zaheen M, Therese Moujalli G, Castelino R. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework. European Journal of Clinical Pharmacology 2022;78(7):1165 View
  14. Vacher A, El Mhamdi S, d’Hollander A, Izotte M, Auroy Y, Michel P, Quenon J. Impact of an Original Methodological Tool on the Identification of Corrective and Preventive Actions After Root Cause Analysis of Adverse Events in Health Care Facilities: Results of a Randomized Controlled Trial. Journal of Patient Safety 2021;17(7):483 View
  15. Cragg A, Small S, Lau E, Rowe A, Lau A, Butcher K, Hohl C. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes. Drug Safety 2023;46(11):1161 View
  16. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacists in Australia: Usability Testing Study. JMIR Formative Research 2023;7:e48976 View
  17. Hutton S, Vance K, Loftus S, Roth G, Van Male L. National Development and Implementation of a Democratized Disruptive Behavior Reporting System in Health Care. Journal of Medical Systems 2023;47(1) View
  18. Lau E, Small S, Butcher K, Cragg A, Loh G, Shalansky S, Hohl C. An external facilitation intervention to increase uptake of an adverse drug event reporting intervention. Frontiers in Health Services 2023;3 View
  19. Lau E, Cragg A, Small S, Butcher K, Hohl C. Characterizing and comparing adverse drug events documented in two spontaneous reporting systems in the Lower Mainland of British Columbia, Canada: A retrospective observational study (Preprint). JMIR Human Factors 2023 View
  20. Ali M, Ademe S, Shumiye M, Hamza A. Patient safety culture and associated factors among health care workers in south Wollo zone public hospitals, north east Ethiopia. Perioperative Care and Operating Room Management 2024;35:100374 View